Gerede Angeliki, Papasozomenou Panayiota, Stavros Sofoklis, Potiris Anastasios, Domali Ekaterini, Nikolettos Nikolaos, Eleftheriades Makarios, Zafrakas Menelaos
Department of Obstetrics and Gynecology, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
School of Health Science, International Hellenic University, 57400 Thessaloniki, Greece.
Medicina (Kaunas). 2025 Jun 30;61(7):1195. doi: 10.3390/medicina61071195.
: Calcium is an essential mineral that plays a vital role in fetal development and maternal health during pregnancy. The World Health Organization recommends a daily calcium intake of 1.5-2 g for pregnant adult women. Calcium deficiency during gestation may lead to complications, such as gestational hypertension, preeclampsia, loss of bone mineral density, impaired fetal development, and other adverse pregnancy outcomes. The aim of the present review is to evaluate the current clinical evidence on calcium intake during pregnancy. : The present systematic review was conducted according to the PRISMA 2020 statement by searching two major databases, PubMed and Mendeley. The study protocol was registered in the Open Science Framework (DOI: osf.io/rvj7z). Inclusion criteria were clinical trials on calcium supplementation during pregnancy. Exclusion criteria were clinical guidelines, reviews, case reports, case series, letters, and commentaries. The Newcastle-Ottawa Scale was used to assess the risk of bias in the included studies. : Initially, 451 publications were identified, and after removal of duplicates and screening of titles and/or abstracts and/or full texts, 34 studies were included. The number of participants ranged between 30 and 22,000 women. Calcium supplementation was associated with lower incidence of and less severe gestational hypertension and preeclampsia, lower risk of preterm birth, longer pregnancy duration and higher neonatal birth weight, and improved maternal bone mineral density postpartum. When the doses were split up into smaller doses, the benefits were strongest with high-dose regimens (1.5-2 g/day). : Calcium supplementation during pregnancy has beneficial effects on maternal and neonatal health, especially in populations with insufficient dietary daily calcium intake and women at high risk of hypertensive disorders. Daily dose may vary according to individual needs, daily dietary calcium intake, and general health status. Further large-scale randomized controlled trials (RCTs) are necessary to confirm these findings.
钙是一种必需矿物质,在孕期胎儿发育和母体健康中起着至关重要的作用。世界卫生组织建议成年孕妇每日钙摄入量为1.5 - 2克。孕期缺钙可能导致并发症,如妊娠期高血压、先兆子痫、骨矿物质密度降低、胎儿发育受损以及其他不良妊娠结局。本综述的目的是评估当前关于孕期钙摄入的临床证据。:本系统综述按照PRISMA 2020声明进行,通过检索两个主要数据库,即PubMed和Mendeley。研究方案已在开放科学框架(DOI:osf.io/rvj7z)中注册。纳入标准为孕期补钙的临床试验。排除标准为临床指南、综述、病例报告、病例系列、信函和评论。采用纽卡斯尔 - 渥太华量表评估纳入研究的偏倚风险。:最初识别出451篇出版物,在去除重复项并筛选标题和/或摘要和/或全文后,纳入了34项研究。参与者数量在30至22,000名女性之间。补钙与妊娠期高血压和先兆子痫的发病率降低、病情减轻、早产风险降低、孕期延长、新生儿出生体重增加以及产后母体骨矿物质密度改善相关。当剂量分为较小剂量时,高剂量方案(1.5 - 2克/天)的益处最为显著。:孕期补钙对母体和新生儿健康有益,尤其是在日常饮食钙摄入量不足的人群以及患有高血压疾病高风险的女性中。每日剂量可能因个体需求、每日饮食钙摄入量和总体健康状况而异。需要进一步的大规模随机对照试验(RCT)来证实这些发现。